These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 2698501

  • 21. Treatment of refractory multiple myeloma with vincristine, adriamycin, dexamethasone, and with repeated application of cyclophosphamide (C-VAD).
    Adam Z, Elbl L, Vorlicek J, Hájek R, Hájek D, Hejlová N, Králová E, Novotná H.
    Acta Med Austriaca; 1994; 21(4):111-5. PubMed ID: 7871966
    [Abstract] [Full Text] [Related]

  • 22. [Chemotherapy of multiple myeloma].
    Golenkov AK.
    Sov Med; 1991; (3):43-6. PubMed ID: 1882290
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Chemotherapy and immunomodulating treatment of patients with multiple myeloma].
    Kraj M, Dmoszyńska A, Maj S, Kowalewski J, Rostkowska J, Pogłód R, Sokołowska B, Mendek-Czajkowska E, Kurowska M, Sokołowska U.
    Acta Haematol Pol; 1991; 22(1):4-20. PubMed ID: 1823965
    [Abstract] [Full Text] [Related]

  • 28. [Heterogenicity of the response to chemotherapy in plasmablastic myeloma].
    Paule B, Quillard J, Bisson M, Massias P.
    Nouv Rev Fr Hematol (1978); 1987; 29(6):391-6. PubMed ID: 2454453
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Feasibility and outcome of tandem stem cell autotransplants in multiple myeloma.
    Galli M, Nicolucci A, Valentini M, Belfiglio M, Delaini F, Crippa C, Barbui AM, Giussani U, Rambaldi A, Barbui T.
    Haematologica; 2005 Dec; 90(12):1643-9. PubMed ID: 16330437
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone.
    Kyle RA, Pajak TF, Henderson ES, Nawabi IU, Brunner K, Henry PH, McIntyre OR, Holland JF.
    Cancer Treat Rep; 1982 Mar; 66(3):451-6. PubMed ID: 7060034
    [Abstract] [Full Text] [Related]

  • 34. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
    Gertz MA, Lacy MQ, Inwards DJ, Chen MG, Pineda AA, Gastineau DA, Greipp PR, Lust JA, Tefferi A, Witzig TE, Kyle RA, Litzow MR.
    Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
    [Abstract] [Full Text] [Related]

  • 35. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
    [Abstract] [Full Text] [Related]

  • 36. High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe.
    Fermand JP, Katsahian S, Divine M, Leblond V, Dreyfus F, Macro M, Arnulf B, Royer B, Mariette X, Pertuiset E, Belanger C, Janvier M, Chevret S, Brouet JC, Ravaud P, Group Myelome-Autogreffe.
    J Clin Oncol; 2005 Dec 20; 23(36):9227-33. PubMed ID: 16275936
    [Abstract] [Full Text] [Related]

  • 37. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD, Wolff SN, Stein RS, Greer JP, Cousar JB, Greco FA.
    Cancer Treat Rep; 1986 Aug 20; 70(8):953-8. PubMed ID: 3015406
    [Abstract] [Full Text] [Related]

  • 38. [Combination chemotherapy of multiple myeloma].
    Uzuka Y, Saito Y, Ito T.
    Gan To Kagaku Ryoho; 1990 Aug 20; 17(8 Pt 1):1481-7. PubMed ID: 2389944
    [Abstract] [Full Text] [Related]

  • 39. Combined alpha-2C-interferon/VMCP polychemotherapy versus VMCP polychemotherapy as induction therapy in multiple myeloma: a prospective randomized trial.
    Scheithauer W, Cortelezzi A, Fritz E, Kührer I, Polli E, Baldini L, Ludwig H.
    J Biol Response Mod; 1989 Apr 20; 8(2):109-15. PubMed ID: 2659740
    [Abstract] [Full Text] [Related]

  • 40. [Value of successive chemotherapy in multiple myeloma of bone. Prospective study over 4 years].
    Bataille R, Morlock G, Rosenberg F, Lopitaux R, Blotman F, Sany J, Ciurana AJ, Rampon S, Bussière JL, Simon L, Serre H.
    Rev Rhum Mal Osteoartic; 1980 Feb 20; 47(2):77-82. PubMed ID: 7361063
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.